Published in Arch Dermatol on May 01, 1994
Skin adnexal neoplasms--part 1: an approach to tumours of the pilosebaceous unit. J Clin Pathol (2006) 1.80
CD34+ fibrocytes, alpha-smooth muscle antigen-positive myofibroblasts, and CD117 expression in the stroma of invasive squamous cell carcinomas of the oral cavity, pharynx, and larynx. Virchows Arch (2004) 1.15
Multiple familial trichoepithelioma with malignant transformation. Indian J Dermatol (2013) 0.98
CD10 expression helps to differentiate basal cell carcinoma from trichoepithelioma. J Res Med Sci (2011) 0.92
Giant solitary trichoepithelioma. South Asian J Cancer (2015) 0.84
CD34(+) fibrocytes in melanocytic nevi and malignant melanomas of the skin. Virchows Arch (2008) 0.82
Fibroepithelioma of Pinkus Revisited. Dermatol Ther (Heidelb) (2016) 0.78
Significance of androgen receptor and CD10 expression in cutaneous basal cell carcinoma and trichoepithelioma. Oncol Lett (2015) 0.78
Composite Tumor Associating Trichoblastoma and Seborrheic Keratosis. Ann Dermatol (2015) 0.75
Blood vessel density in Basal cell carcinomas and benign trichogenic tumors as a marker for differential diagnosis in dermatopathology. J Skin Cancer (2010) 0.75
Immunostaining for CD34 to determine trichoepithelioma. Arch Dermatol (1995) 0.75
CD34, stem cells, and the skin. Arch Dermatol (1994) 0.75
[Basal cell carcinoma and rare form variants]. Pathologe (2014) 0.75
Cycling CD34 expression in subpopulations of head and neck squamous cell carcinoma cell lines is involved in radioresistance and change in cytokeratin expression profile. Clin Exp Med (2016) 0.75
A novel AKT3 mutation in melanoma tumours and cell lines. Br J Cancer (2008) 2.63
Utility of step sections: demonstration of additional pathological findings in biopsy samples initially diagnosed as actinic keratosis. Arch Dermatol (2000) 2.12
Follicular mucinosis in Hodgkin's disease: a poor prognostic sign? J Am Acad Dermatol (1991) 2.05
Evaluation of classic architectural criteria in non-mycosis fungoides cutaneous lymphomas. Am J Dermatopathol (1997) 1.96
Allelic and locus heterogeneity in inherited venous malformations. Hum Mol Genet (1999) 1.78
Immunohistochemical demonstration of factor XIIIa expression in neurofibromas. A practical means of differentiating these tumors from neurotized melanocytic nevi and schwannomas. Arch Dermatol (1990) 1.70
Basal cell carcinoma: a comparison of shave biopsy versus punch biopsy techniques in subtype diagnosis. J Am Acad Dermatol (1999) 1.66
Paraneoplastic pemphigus with autoantibody deposition in bronchial epithelium after autologous bone marrow transplantation. JAMA (1992) 1.60
Melanoma of the gallbladder: a review of cases seen at Duke University Medical Center. Cancer (1999) 1.54
Inducible nitric oxide synthase and nitrotyrosine in human metastatic melanoma tumors correlate with poor survival. Clin Cancer Res (2000) 1.52
Port-wine stains. A disease of altered neural modulation of blood vessels? Arch Dermatol (1986) 1.43
Phase II trial of imatinib mesylate in patients with metastatic melanoma. Br J Cancer (2008) 1.43
Differentiation and clonality of lesional lymphocytes in small plaque parapsoriasis. Arch Dermatol (1995) 1.40
Increased p53 staining in normal skin of posttransplant, immunocompromised patients and implications for carcinogenesis. Am J Dermatopathol (1999) 1.40
Leukemia cutis. Analysis of 50 biopsy-proven cases with an emphasis on occurrence in myelodysplastic syndromes. Am J Clin Pathol (1993) 1.39
Differential sensitivity of estrogen/progesterone receptors and BRST-2 markers in metastatic ductal and lobular breast carcinoma to the skin. Am J Dermatopathol (1996) 1.39
Immunohistochemical evaluation of androgen receptors in genital and extragenital lichen sclerosus: evidence for loss of androgen receptors in lesional epidermis. J Am Acad Dermatol (1999) 1.39
Cutaneous epithelioid angioleiomyoma. Am J Dermatopathol (1998) 1.31
Progesterone receptor positivity supports hormonal control of syringomas. J Cutan Pathol (1995) 1.30
Pagetoid reticulosis (Woringer-Kolopp disease): an immunophenotypic, molecular, and clinicopathologic study. Mod Pathol (2000) 1.26
Mutation and expression of the p53 gene in human malignant melanoma. Melanoma Res (1994) 1.24
Down-regulated melanoma differentiation associated gene (mda-7) expression in human melanomas. Int J Cancer (2001) 1.19
Expression of transforming growth factor-beta 2 in malignant melanoma correlates with the depth of tumor invasion. Implications for tumor progression. Am J Pathol (1994) 1.19
Phlebotomy for diagnostic laboratory tests in adults. Pattern of use and effect on transfusion requirements. N Engl J Med (1986) 1.18
Atypical fibroxanthoma. Multiple immunohistologic profiles. Am J Surg Pathol (1993) 1.17
Bloodless glucose measurements. Crit Rev Ther Drug Carrier Syst (1998) 1.11
Histological study of necrolytic acral erythema. J Ark Med Soc (2004) 1.07
Primary malignant melanoma of the esophagus. J Surg Oncol (1997) 1.04
Mycosis fungoides: classic disease and variant presentations. Semin Cutan Med Surg (2000) 1.02
Benign cutaneous polyarteritis nodosa. Relationship to systemic polyarteritis nodosa and to hepatitis B infection. Arch Dermatol (1991) 1.01
Porokeratosis in immunosuppressed and nonimmunosuppressed patients. Int J Dermatol (1992) 1.01
The spectrum of cutaneous disease in leukemias. J Cutan Pathol (1993) 1.01
Indeterminate fibrohistiocytic lesions of the skin: is there a spectrum between dermatofibroma and dermatofibrosarcoma protuberans? Am J Surg Pathol (2000) 0.98
Evaluation and surgical resection of adrenal masses in patients with a history of extra-adrenal malignancy. Surgery (2001) 0.97
Agreement of dermatopathologists in the evaluation of clinically difficult melanocytic lesions: how golden is the 'gold standard'? Dermatology (2012) 0.97
The expression of syndecan-1 is preferentially reduced compared with that of E-cadherin in acantholytic squamous cell carcinoma. J Cutan Pathol (2001) 0.96
Leukocytoclastic (small vessel) vasculitis in multiple myeloma. Clin Exp Dermatol (2003) 0.96
Value of skin biopsies in assessing prognosis and progression of acute graft-versus-host disease. Am J Surg Pathol (1997) 0.95
Expression of bcl-2 protein and Ki-67 nuclear proliferation antigen in benign and malignant cutaneous T-cell infiltrates. J Cutan Pathol (1995) 0.95
Neurofibromas and neurotized melanocytic nevi are immunohistochemically distinct neoplasms. Am J Dermatopathol (1990) 0.94
Absence of Borrelia burgdorferi DNA in cutaneous B-cell lymphomas from the United States. J Cutan Pathol (2001) 0.94
Benign lymphangioendothelioma. J Am Acad Dermatol (1994) 0.93
Trichoepithelioma: a 19-year clinicopathologic re-evaluation. J Cutan Pathol (1999) 0.93
Evidence against a role for human T-cell lymphotrophic virus type I (HTLV-I) in the pathogenesis of American cutaneous T-cell lymphoma. J Invest Dermatol (1996) 0.93
Multimethod imaging, staging, and spectrum of manifestations of metastatic melanoma. Clin Radiol (2011) 0.93
Estrogen and progesterone receptors and anti-gross cystic disease fluid protein 15 (BRST-2) fail to distinguish metastatic breast carcinoma from eccrine neoplasms. Mod Pathol (1995) 0.90
Sentinel lymph node biopsy for conjunctival melanoma. Ophthal Plast Reconstr Surg (2001) 0.90
Trichoepithelioma with an adjacent basal cell carcinoma, transformation or collision? J Am Acad Dermatol (1997) 0.90
Intraepidermal nerve fiber expression of calcitonin gene-related peptide, vasoactive intestinal peptide and substance P in psoriasis. Arch Dermatol Res (1997) 0.89
Vascular endothelial growth factor expression in malignant melanoma: prognostic versus diagnostic usefulness. Mod Pathol (1999) 0.89
Aggressive cutaneous NK and NK-like T-cell lymphomas: clinicopathologic, immunohistochemical, and molecular analyses of 12 cases. Am J Surg Pathol (1999) 0.88
Grover's disease (transient acantholytic dermatosis): relationship of acantholysis to acrosyringia. J Cutan Pathol (1998) 0.87
Correlating architectural disorder and cytologic atypia in Clark (dysplastic) melanocytic nevi. Hum Pathol (1999) 0.87
Multiple lesions of intravascular papillary endothelial hyperplasia (Masson's lesions). Arch Pathol Lab Med (1994) 0.87
Epstein Barr virus-associated lymphoproliferative-disorders primarily involving the skin. J Cutan Pathol (1999) 0.86
Immunofluorescent microscopic investigation of the distal arrector pili: a demonstration of the spatial relationship between alpha5beta1 integrin and fibronectin. J Am Acad Dermatol (2000) 0.86
Microcystic adnexal carcinoma arising in the setting of previous radiation therapy. J Cutan Pathol (1999) 0.86
bcl-2 expression in primary malignancies of the skin. Arch Dermatol (1995) 0.86
The microanatomy of the distal arrector pili: possible role for alpha1beta1 and alpha5beta1 integrins in mediating cell-cell adhesion and anchorage to the extracellular matrix. J Cutan Pathol (2000) 0.86
Expression of CD34 in sclerotic ("plywood") fibromas. Am J Dermatopathol (2000) 0.86
High-intensity flashlamp photoepilation: a clinical, histological, and mechanistic study in human skin. Arch Dermatol (1999) 0.85
Recurrent melanocytic nevus: a histologic and immunohistochemical evaluation. J Cutan Pathol (2001) 0.85
Solitary fibrous tumors are immunophenotypically distinct from mesothelioma(s). J Cutan Pathol (2000) 0.85
Cutaneous nodules of Mycobacterium chelonae in an immunosuppressed patient with preexisting pulmonary colonization. J Am Acad Dermatol (1993) 0.85
Keratoacanthoma and squamous cell carcinoma of the skin: immunohistochemical localization of involucrin and keratin proteins. J Am Acad Dermatol (1986) 0.85
Mast cells in angiolipomas and hemangiomas of human skin: are they important for angiogenesis? J Cutan Pathol (1994) 0.85
Long-term photoepilation using a broad-spectrum intense pulsed light source. Arch Dermatol (2000) 0.84
Expression of the human erythrocyte glucose transporter Glut-1 in areas of sclerotic collagen in necrobiosis lipoidica. J Cutan Pathol (2001) 0.84
Alopecia universalis in an HIV-positive patient: possible insight into pathogenesis. J Cutan Pathol (1993) 0.84
Lymphocytes infiltrating primary cutaneous neoplasms selectively express the cutaneous lymphocyte-associated antigen (CLA). Am J Pathol (1993) 0.84
Proliferation and apoptosis within juvenile capillary hemangiomas. Am J Dermatopathol (1996) 0.84
Desmoplastic (sclerotic) nevus: an underrecognized entity that resembles dermatofibroma and desmoplastic melanoma. Am J Surg Pathol (1999) 0.84
Low-fluence carbon dioxide laser irradiation of lentigines. Arch Dermatol (1988) 0.83
Primary chondroid melanoma. J Cutan Pathol (2001) 0.83
Cutaneous Langerhans cell histiocytosis of the genitalia in the elderly: a report of three cases. J Cutan Pathol (1998) 0.83
Port-wine stains: a new hypothesis. J Am Acad Dermatol (1987) 0.83
The role of androgen receptors in the clinical course of nevus sebaceus of Jadassohn. Mod Pathol (2001) 0.82
Use of CD34 in assessing the relationship between stroma and tumor in desmoplastic keratinocytic neoplasms. J Cutan Pathol (1995) 0.82
Quantitation of intraepidermal T-cell subsets in formalin-fixed, paraffin-embedded tissue helps in the diagnosis of mycosis fungoides. J Cutan Pathol (1999) 0.82
Restrictive dermopathy. Report of two affected siblings and a review of the literature. Arch Dermatol (1992) 0.82
Keratotic melanocytic nevus: a clinicopathologic and immunohistochemical study. J Cutan Pathol (2000) 0.82
Thickness of superficial basal cell carcinoma (sBCC) predicts imiquimod efficacy: a proposal for a thickness-based definition of sBCC. Br J Dermatol (2013) 0.81
Immunohistochemical stains in dermatopathology. J Am Acad Dermatol (2000) 0.81
A novel preclinical model of human malignant melanoma utilizing bioreactor rotating-wall vessels. In Vitro Cell Dev Biol Anim (2001) 0.81
Syndecan-1 expression is diminished in acantholytic cutaneous squamous cell carcinoma. J Cutan Pathol (1999) 0.80
The differential diagnosis of pagetoid cells in the epidermis. Mod Pathol (1998) 0.80
Immunohistochemistry in diagnostic dermatopathology. Dermatol Clin (1999) 0.80
Malignant melanoma with paradoxical maturation. Am J Surg Pathol (2000) 0.80
Nerve growth factor and its receptor system in psoriasis. Br J Dermatol (2000) 0.80
Syndecan-1 expression is decreased with increasing aggressiveness of basal cell carcinoma. Am J Dermatopathol (2000) 0.80
Absence of human herpesvirus 8 and Epstein-Barr virus genome sequences in cutaneous epithelial neoplasms arising in immunosuppressed organ-transplant patients. J Cutan Pathol (1997) 0.79
Reassessment of lymphocytic atypia in the diagnosis of mycosis fungoides. Mod Pathol (2001) 0.79
bcl-2 expression in melanocytic nevi. Insights into the biology of dermal maturation. Arch Dermatol (1995) 0.79
Relationship of factor XIIIa-positive dermal dendrocytes to Kaposi's sarcoma. Arch Pathol Lab Med (1991) 0.79
Estrogen and progesterone receptors in androgenic alopecia versus alopecia areata. Am J Dermatopathol (1998) 0.79
Cutaneous myiasis following travel to Belize. Int J Dermatol (1996) 0.79